NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT00003107 2014-09-10Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsIndiana UniversityPhase 1 Completed
NCT00024063 2013-12-19SU006668 in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Unknown